Matches in Nanopublications for { ?s ?p "[Our findings illuminate the mechanistic details of KRAS-mediated drug resistance and provide a preclinical rationale to improve the management of lung tumors harboring KRAS mutations with NRF2 pathway inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- assertion description "[Our findings illuminate the mechanistic details of KRAS-mediated drug resistance and provide a preclinical rationale to improve the management of lung tumors harboring KRAS mutations with NRF2 pathway inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP589195.RAeOHUI2wuULD2utK8AjTm17CDo7ZW3mfnyTH0Iyg1XB4130_assertion description "[Our findings illuminate the mechanistic details of KRAS-mediated drug resistance and provide a preclinical rationale to improve the management of lung tumors harboring KRAS mutations with NRF2 pathway inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP589195.RAeOHUI2wuULD2utK8AjTm17CDo7ZW3mfnyTH0Iyg1XB4130_provenance.
- assertion description "[Our findings illuminate the mechanistic details of KRAS-mediated drug resistance and provide a preclinical rationale to improve the management of lung tumors harboring KRAS mutations with NRF2 pathway inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Our findings illuminate the mechanistic details of KRAS-mediated drug resistance and provide a preclinical rationale to improve the management of lung tumors harboring KRAS mutations with NRF2 pathway inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1231936.RABA48oZ6qSdu9kjLHRwTS63ts7-1o3Y70xBU21ojYfVA130_assertion description "[Our findings illuminate the mechanistic details of KRAS-mediated drug resistance and provide a preclinical rationale to improve the management of lung tumors harboring KRAS mutations with NRF2 pathway inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1231936.RABA48oZ6qSdu9kjLHRwTS63ts7-1o3Y70xBU21ojYfVA130_provenance.
- NP1231937.RADVXMLQD8YG-RFTTTOVJjpqoaMaQ5KUQNPPTt0Py04ro130_assertion description "[Our findings illuminate the mechanistic details of KRAS-mediated drug resistance and provide a preclinical rationale to improve the management of lung tumors harboring KRAS mutations with NRF2 pathway inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1231937.RADVXMLQD8YG-RFTTTOVJjpqoaMaQ5KUQNPPTt0Py04ro130_provenance.
- NP1231935.RAuvMt7bQKLAh44M_Xrd2pPak_b8H0mmXWyV-osA0neBA130_assertion description "[Our findings illuminate the mechanistic details of KRAS-mediated drug resistance and provide a preclinical rationale to improve the management of lung tumors harboring KRAS mutations with NRF2 pathway inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1231935.RAuvMt7bQKLAh44M_Xrd2pPak_b8H0mmXWyV-osA0neBA130_provenance.
- NP416427.RA7LacyRoTpw1tRaZpc3fE_1ayoG8CKmAjMWitxItS1Sg130_assertion description "[Our findings illuminate the mechanistic details of KRAS-mediated drug resistance and provide a preclinical rationale to improve the management of lung tumors harboring KRAS mutations with NRF2 pathway inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP416427.RA7LacyRoTpw1tRaZpc3fE_1ayoG8CKmAjMWitxItS1Sg130_provenance.
- NP527347.RAOEoGnxor9z3oXdtHnn742EeHIT2Wj2g0KQcTTRsPRhk130_assertion description "[Our findings illuminate the mechanistic details of KRAS-mediated drug resistance and provide a preclinical rationale to improve the management of lung tumors harboring KRAS mutations with NRF2 pathway inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP527347.RAOEoGnxor9z3oXdtHnn742EeHIT2Wj2g0KQcTTRsPRhk130_provenance.